Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals (VRTX) Financial Statements


Vertex Pharmaceuticals Financial Overview

Vertex Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $12.936; its P/E ratio is 27.03; Vertex Pharmaceuticals is scheduled to report earnings on November 1, 2023, and the estimated EPS forecast is $3.92. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 2.49B$ 2.37B$ 2.30B$ 2.33B$ 2.20B
Gross Profit$ 2.18B$ 2.11B$ 2.02B$ 2.04B$ 1.93B
EBIT$ 1.17B$ 902.90M$ 1.09B$ 1.19B$ 1.04B
EBITDA$ 1.21B$ 941.70M-$ 1.23B$ 1.08B
Net Income Common Stockholders$ 915.70M$ 699.80M$ 818.90M$ 930.50M$ 810.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.24B$ 10.41B$ 10.78B$ 9.77B$ 9.25B
Total Assets$ 20.35B$ 18.97B$ 18.16B$ 16.71B$ 15.58B
Total Debt$ 767.60M$ 789.20M$ 810.30M$ 824.60M$ 847.30M
Net Debt$ -10.47B$ -9.62B$ -9.97B$ -8.95B$ -8.41B
Total Liabilities$ 4.88B$ 4.54B$ 18.15B$ 3.68B$ 3.65B
Stockholders Equity$ 15.47B$ 14.43B$ 13.91B$ 13.03B$ 11.93B
Cash Flow-
Free Cash Flow$ 1.08B$ 859.70M$ 1.04B$ 901.30M$ 1.09B
Operating Cash Flow$ 1.14B$ 901.80M$ 1.08B$ 955.50M$ 1.14B
Investing Cash Flow$ -304.50M$ -1.84B$ 177.40M$ -384.20M$ -61.50M
Financing Cash Flow$ 17.30M$ -294.70M$ 40.20M$ -60.20M$ 47.70M
Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History

Vertex Pharmaceuticals Debt to Assets

Vertex Pharmaceuticals Cash Flow

Vertex Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis